Fondazione Policlinico Universitario Agostino Gemelli

Rome 00168

1 studies enrolling now · 10 studies all time

What they study most

Aneurysmal Subarachnoid Hemorrhage, Castration-resistant Prostate Cancer, Cerebral Vasospasm, Colorectal Cancer, Colorectal Neoplasms, Cutaneous Squamous Cell Carcinoma, Duchenne Muscular Dystrophy, Heart Failure, Hepatocellular Carcinoma, Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome), Non-Small Cell Lung Cancer, Ovarian Cancer

Studies at this site

• Nitric Oxide Consumption as a Predictor of Vasospasm in Subarachnoid Hemorrhage — Recruiting now
• An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM) — Running, not enrolling
• A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors — Stopped early
• A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX) — Stopped early
• Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD) — Stopped early
• Study of Cilofexor in Adults With Primary Sclerosing Cholangitis — Stopped early
• Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry — Completed
• Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer — Completed
• Study of Tepotinib Combined With Cetuximab in Participants With Left-Sided RAS/BRAF Wild Type Metastatic Colorectal Cancer (PERSPECTIVE) — Stopped early
• Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy — Completed